Rebecca Ashfield Jenner Institute, University of Oxford (ORCRB Roosevelt Drive Oxford OX3 7DQ). BA (1st class) Oxford, DPhil Oxford, over 20 years working in field of immunotherapy and vaccine development. Currently CSO of Ducentis Biotherapeutics Ltd and Senior Project Manager at the Jenner Institute. Organiser/co-leader of several vaccinology courses in Oxford and Leiden. Edited most recent Jenner Institute triennial report. Expertise in vaccine GMP manufacture, led successful application to Innovate UK for £75M vaccine innovation and manufacturing centre, currently being built at Harwell in Oxfordshire. H=20 Angus Nnamdi Oli Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU), Agulu Campus (Post code 422001, Agulu, Anambra State, Nigeria). BPharm. and MPharm. UNN, DPhil NAU and a DPharm. University of Benin, Nigeria. Currently a Senior Lecturer with over 8 years’ experience. Author of several articles in peer-reviewed journals indexed in Pubmed, Web of Science and Scopus. Current research interests/career goals are Infection and immunology of infectious diseases with emphasis of viral and bacterial infections, development of effective vaccines with strong antibody and T lymphocytes effect or responses against the infections, Pharmaceutical Quality Systems and Clinical vaccinology. H: 5 Charles Okechukwu Esimone Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU, Main Campus, PMB 5025, Awka, Anambra State, Nigeria). BPharm., MPharm. and PhD in Pharmaceutics, University of Nigeria, Nsukka (UNN). With over 20 years’ experience as a lecturer and research scientist and over 12 years’ experience in vaccinology/immunology research. Currently a Professor and VC of Nnamdi Azikiwe University, Editor-in-Chief of the Journal of Current Biomedical Research and the Biomedical Research Committee, currently chaired by me, focuses on the development of biotechnological products such as vaccines for tropical diseases, amongst other interest. H: 18 Linda Onyeka Anagu Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU), Agulu Campus (Post code 422001, Agulu, Anambra State, Nigeria). BPharm. and MPharm. UNN, DPhil Keele University. With over 8 years’ experience as a lecturer and research scientist. She has interest in vaccine design/development processes that borders on her expertise in molecular cloning and Plasmodium epigenetics. Recently, attended the Vaccinology Summer School organized by Dr. Rebecca Ashfield and the late Dr. Sahid Khan in Leiden. Edited the recent, 2015 edition of LABORATORY HANDBOOK OF PHARMACEUTICAL MICROBIOLOGY AND BIOTECHNOLOGY, used by undergraduate and postgraduate students at Nnamdi Azikiwe University. ERC H: 5

Select Guide Rating

• 1. Immunology and the Concept of VaccinationRebecca Chukwuanukwu, A. Ehiaghe, A. Rowaiye and Angus Nnamdi Oli2. Vaccine Types and Reverse VaccinologyA. Rowaiye and Angus Nnamdi Oli3. Dendritic Cells as Vaccine TargetsP. Aondona, F. Iseghohi, A. Rowaiye and Angus Nnamdi Oli4. Vaccine Development: From the Laboratory to the FieldNana Efua Andoh and Linda Onyeka Anagu5. Immunopeptidomics for the Identification of T cell Vaccine TargetsP. Bettencourt and C. Barbosa6. Virus Like Particle VaccinesAhmed M. Salman, Ekta Mukhopadhyay and Adrian Hill7. Approaches to Cancer VaccinationEzinne Janefrances Nwonu8. Vaccines against SARS-CoV-2K. Ewer and Andrés Noé9. Adjuvants, Immunomodulators and Adaptogens Anita Milicic, M. Ugwu, Sabina Górska, Agnieszka Razim, M. Luchner, Slavcho Mrenoshki, H. Kefei, G. Corby, A. Thakur, Sveinbjorn Gizurarson, J. Fergusson, Dennis Christensen, S. Ercelen, S. Longet, B. Morein, E. Lindblad and S. Reinke10. GMP Manufacture and Quality Control ChapterRebecca Ashfield11. Testing Vaccines: Essential Steps in Clinical Trial DesignJulia Marshall